We want to offer the health care a more precise, simpler and less costly diagnosis of cancers and other diseases.
Currently, reliable diagnostic methods in preoperative evaluation, for lymphatic spread in rectal cancer patients are lacking – in particular, methods to rule out that rectal cancer has spread to the lymph nodes. We have identified a void in today’s care and a great need for a more reliable rectal cancer staging.
At NanoEcho, we specialize in a novel, user-friendly imaging method known as magnetomotive ultrasound. As the contrast agent for medical ultrasound imaging, we use iron-oxide-based nanoparticles. The images are generated by visualizing NanoTrace® signals and are intended to facilitate the differentiation between diseased and healthy tissue. The method makes it possible to detect cancer spread to the lymph nodes before surgery.
Thanks to a higher precision, the method has the potential to meet the need for a more reliable staging of rectal cancer patients by providing a better mapping of the cancer spread to nearby lymph nodes.
The company was founded in 2013 as a spinoff from a group of researchers at the Department of Biomedical Engineering at Lund University. NanoEcho is a Swedish medtech company seated in Lund.